Characteristics, Outcomes of US Children, Adolescents With Multisystem Inflammatory Syndrome in Children Compared With Severe COVID-19

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, FEBRUARY 24, 2021

Media advisory: The full studyis linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2091?guestAccessKey=927d5030-3122-4dbf-936f-acfd0321e41e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=022421

 

What The Study Did: National COVID-19 registry data are used in this study to describe the epidemiology, clinical characteristics, complications, and hospital and postdischarge outcomes of pediatric patients with multisystem inflammatory syndrome in children (MIS-C) and to compare each in patients with severe COVID-19.

Authors: Adrienne G. Randolph, M.D., of Boston Children’s Hospital, is the corresponding author.

(doi:10.1001/jama.2021.2091)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.